NCT05241613 2025-02-13
A Study of AC176 for the Treatment of Metastatic Castration Resistant Prostate Cancer
Accutar Biotechnology Inc
Phase 1 Terminated
Accutar Biotechnology Inc
Accutar Biotechnology Inc
National Institutes of Health Clinical Center (CC)